GR activity is also context dependent (Pan et al, 2011): while high GR expression and activation correlate with poor prognosis in TNBC (Obradović et al, 2019), it is associated with a positive outcome in ER+ breast cancer (West et al, 2016). Here, ESR1 is linked to breast cancer.